A detailed history of Adirondack Trust CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Adirondack Trust CO holds 806 shares of BSX stock, worth $61,578. This represents 0.02% of its overall portfolio holdings.

Number of Shares
806
Previous 797 1.13%
Holding current value
$61,578
Previous $46,000 19.57%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$57.6 - $68.62 $518 - $617
9 Added 1.13%
806 $55,000
Q4 2023

Mar 29, 2024

SELL
$48.64 - $57.81 $9,728 - $11,562
-200 Reduced 20.06%
797 $46,000
Q2 2023

Aug 09, 2023

SELL
$49.72 - $54.64 $6,612 - $7,267
-133 Reduced 11.77%
997 $53,000
Q3 2022

Oct 13, 2022

BUY
$36.71 - $109.66 $23,127 - $69,085
630 Added 126.0%
1,130 $44,000
Q2 2022

Jul 06, 2022

BUY
$35.24 - $47.1 $17,620 - $23,550
500 New
500 $19,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.